• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于干细胞的心脏疾病治疗方法:血管生成外泌体的关键作用。

Stem cell-based therapies for cardiac diseases: The critical role of angiogenic exosomes.

机构信息

Department of Nutrition, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

Biofactors. 2021 May;47(3):270-291. doi: 10.1002/biof.1717. Epub 2021 Feb 19.

DOI:10.1002/biof.1717
PMID:33606893
Abstract

Finding effective treatments for cardiac diseases is among the hottest subjects in medicine; cell-based therapies have brought great promises for managing a broad range of life-threatening heart complications such as myocardial infarction. After clarifying the critical role of angiogenesis in tissue repair and regeneration, various stem/progenitor cell were utilized to accelerate the healing of injured cardiac tissue. Embryonic, fetal, adult, and induced pluripotent stem cells have shown the appropriate proangiogenic potential for tissue repair strategies. The capability of stem cells for differentiating into endothelial lineages was initially introduced as the primary mechanism involved in improving angiogenesis and accelerated heart tissue repair. However, recent studies have demonstrated the leading role of paracrine factors secreted by stem cells in advancing neo-vessel formation. Genetically modified stem cells are also being applied for promoting angiogenesis regarding their ability to considerably overexpress and secrete angiogenic bioactive molecules. Yet, conducting further research seems necessary to precisely identify molecular mechanisms behind the proangiogenic potential of stem cells, including the signaling pathways and regulatory molecules such as microRNAs. In conclusion, stem cells' pivotal roles in promoting angiogenesis and consequent improved cardiac healing and remodeling processes should not be ignored, especially in the case of stem cell-derived extracellular vesicles.

摘要

寻找有效的心脏病治疗方法是医学领域最热门的课题之一;基于细胞的疗法为治疗多种危及生命的心脏并发症(如心肌梗死)带来了巨大的希望。在明确血管生成在组织修复和再生中的关键作用后,各种干细胞/祖细胞被用于加速受损心脏组织的愈合。胚胎、胎儿、成体和诱导多能干细胞已显示出在组织修复策略中具有适当的促血管生成潜力。干细胞分化为内皮谱系的能力最初被认为是参与改善血管生成和加速心脏组织修复的主要机制。然而,最近的研究表明,干细胞分泌的旁分泌因子在促进新血管形成方面发挥着主导作用。遗传修饰的干细胞也因其能够大量过表达和分泌血管生成生物活性分子而被应用于促进血管生成。然而,为了精确确定干细胞促血管生成潜力背后的分子机制,包括信号通路和调节分子(如 microRNAs),似乎还需要进一步的研究。总之,干细胞在促进血管生成以及随后改善心脏愈合和重塑过程中的关键作用不容忽视,尤其是在干细胞衍生的细胞外囊泡的情况下。

相似文献

1
Stem cell-based therapies for cardiac diseases: The critical role of angiogenic exosomes.基于干细胞的心脏疾病治疗方法:血管生成外泌体的关键作用。
Biofactors. 2021 May;47(3):270-291. doi: 10.1002/biof.1717. Epub 2021 Feb 19.
2
Unravelling the Biology of Adult Cardiac Stem Cell-Derived Exosomes to Foster Endogenous Cardiac Regeneration and Repair.揭开成年心脏干细胞衍生外泌体的生物学特性,以促进内源性心脏再生和修复。
Int J Mol Sci. 2020 May 25;21(10):3725. doi: 10.3390/ijms21103725.
3
Stem cell and exosome therapies for regenerating damaged myocardium in heart failure.干细胞和外泌体疗法在心力衰竭中再生受损心肌。
Life Sci. 2024 Aug 15;351:122858. doi: 10.1016/j.lfs.2024.122858. Epub 2024 Jun 22.
4
Angiogenesis in the infarcted myocardium.梗死心肌中的血管生成。
Antioxid Redox Signal. 2013 Mar 20;18(9):1100-13. doi: 10.1089/ars.2012.4849. Epub 2012 Sep 25.
5
Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair.用间充质干细胞来源的外泌体预处理心脏干细胞可增强心肌修复。
J Am Heart Assoc. 2016 Jan 25;5(1):e002856. doi: 10.1161/JAHA.115.002856.
6
Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRIN.心肌祖细胞和间充质干细胞来源的外泌体通过 EMMPRIN 刺激血管生成。
Adv Healthc Mater. 2016 Oct;5(19):2555-2565. doi: 10.1002/adhm.201600308. Epub 2016 Aug 29.
7
Exosomes in Myocardial Repair: Advances and Challenges in the Development of Next-Generation Therapeutics.心肌修复中的细胞外囊泡:新一代治疗药物开发的进展与挑战。
Mol Ther. 2018 Jul 5;26(7):1635-1643. doi: 10.1016/j.ymthe.2018.04.024. Epub 2018 May 3.
8
Emerging Role of Stem Cells - Derived Exosomes as Valuable Tools for Cardiovascular Therapy.干细胞衍生外泌体作为心血管治疗的重要工具的新兴作用。
Curr Stem Cell Res Ther. 2017;12(2):134-138. doi: 10.2174/1574888X10666151026115320.
9
Exosomes Derived from Akt-Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet-Derived Growth Factor D.Akt 修饰的人脐带间充质干细胞来源的外泌体通过激活血小板衍生生长因子 D 改善心脏再生和促进血管生成。
Stem Cells Transl Med. 2017 Jan;6(1):51-59. doi: 10.5966/sctm.2016-0038. Epub 2016 Sep 22.
10
Stem cells and exosomes in cardiac repair.心脏修复中的干细胞与外泌体。
Curr Opin Pharmacol. 2016 Apr;27:19-23. doi: 10.1016/j.coph.2016.01.003. Epub 2016 Feb 3.

引用本文的文献

1
Stem Cell Therapy Approaches for Ischemia: Assessing Current Innovations and Future Directions.用于缺血的干细胞治疗方法:评估当前创新与未来方向
Int J Mol Sci. 2025 Jun 30;26(13):6320. doi: 10.3390/ijms26136320.
2
M2 macrophage-derived exosomes promote angiogenesis and improve cardiac function after myocardial infarction.M2 巨噬细胞来源的外泌体促进心肌梗死后的血管生成和改善心功能。
Biol Direct. 2024 Jun 6;19(1):43. doi: 10.1186/s13062-024-00485-y.
3
Pleiotropic attenuating effect of against isoprenaline-induced myocardial infarction via improving Bcl-2/mTOR/ERK1/2/Na, K-ATPase activities.
通过改善Bcl-2/mTOR/ERK1/2/钠钾ATP酶活性,[药物名称]对异丙肾上腺素诱导的心肌梗死具有多效性减轻作用。
Chin Herb Med. 2023 Nov 28;16(2):282-292. doi: 10.1016/j.chmed.2023.11.001. eCollection 2024 Apr.
4
Pluronic F-127 Hydrogel Loaded with Human Adipose-Derived Stem Cell-Derived Exosomes Improve Fat Graft Survival via HIF-1α-Mediated Enhancement of Angiogenesis.负载人脂肪来源干细胞衍生外泌体的泊洛沙姆 F-127 水凝胶通过 HIF-1α 介导的血管生成增强改善脂肪移植物的存活率。
Int J Nanomedicine. 2023 Nov 16;18:6781-6796. doi: 10.2147/IJN.S435106. eCollection 2023.
5
Repair of osteochondral defects: efficacy of a tissue-engineered hybrid implant containing both human MSC and human iPSC-cartilaginous particles.骨软骨缺损的修复:含人骨髓间充质干细胞和人诱导多能干细胞软骨颗粒的组织工程混合植入物的疗效
NPJ Regen Med. 2023 Oct 19;8(1):59. doi: 10.1038/s41536-023-00335-x.
6
Isolation of Swine Bone Marrow Lin-/CD45-/CD133 + Cells and Cardio-protective Effects of its Exosomes.猪骨髓 Lin-/CD45-/CD133+ 细胞的分离及其外泌体的心脏保护作用。
Stem Cell Rev Rep. 2023 Jan;19(1):213-229. doi: 10.1007/s12015-022-10432-x. Epub 2022 Aug 4.
7
Stem cell-mediated angiogenesis in skin tissue engineering and wound healing.干细胞介导的皮肤组织工程和创伤愈合中的血管生成。
Wound Repair Regen. 2022 Jul;30(4):421-435. doi: 10.1111/wrr.13033. Epub 2022 Jun 14.
8
Development of meniscus cartilage using polycaprolactone and decellularized meniscus surface modified by gelatin, hyaluronic acid biomacromolecules: A rabbit model.利用聚己内酯和明胶、透明质酸生物大分子修饰去细胞半月板表面开发半月板软骨:兔模型。
Int J Biol Macromol. 2022 Jul 31;213:498-515. doi: 10.1016/j.ijbiomac.2022.05.140. Epub 2022 May 24.
9
Characterization of Macroporous Polycaprolactone/Silk Fibroin/Gelatin/Ascorbic Acid Composite Scaffolds and Results in a Rabbit Model for Meniscus Cartilage Repair.多孔聚己内酯/丝素蛋白/明胶/抗坏血酸复合支架的表征及在兔半月板软骨修复模型中的结果。
Cartilage. 2021 Dec;13(2_suppl):1583S-1601S. doi: 10.1177/19476035211035418. Epub 2021 Aug 2.